Weekly Events | Insilico Medicine executives at CPIC: navigating the dual breakthrough of tech innovation and clinical validation in AI drug discovery
Meeting Announcement
Dr. Alex Zhavoronkov, Founder and Co-CEO of Insilico Medicine, and Dr. Feng Ren, Co-CEO and Chief Scientific Officer, have been invited to attend the inaugural China Pioneer Innovative Drug Global Congress (CPIC 2026), which will grandly convene at the National Exhibition and Convention Center (Shanghai) from July 22 to 24. During this premier event, the two industry leaders will appear at several high-profile forums to deliver keynote speeches, sharing deep insights on how cutting-edge AI combines with "China Speed" to decode the mysteries of life and reshape the global drug R&D landscape.
Dr. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, has been invited to attend BIO Asia-Taiwan, which will be held from July 15 to 19 in Taiwan, China.
Join us July 25–28 in National Harbor, Maryland, just outside Washington, D.C. for the annual flagship meeting of the American Society for Nutrition. With a complimentary press pass, qualifying journalists can be among the first to hear the newest research findings and connect with leaders in nutrition science, practice and policy.